A day before they were supposed to choose a company to manage Maryland's prescription drug benefit program, officials on Tuesday halted consideration of the $2.3 billion contract, amid concerns about the low bidder's past legal problems and reservations about spending the money out of state.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.